Double-blind trial of amoxycillin and ampicillin plus probenecid in the treatment of gonorrhoea in men.
AUTOR(ES)
Brathwaite, A R
RESUMO
In a double-blind study amoxycillin 3 g or ampicillin 3 g plus probenecid 1 g were randomly administered as a single oral dose to 160 men with uncomplicated gonococcal urethritis. The cure rate for each drug group was 98.6%. Tolerance to oral medication was good and no evidence of allergy or toxicity to either drug was shown. No case of post-gonococcal urethritis was observed over a 14-day follow-up period. Thus, both drug regimens proved very effective in treating uncomplicated gonococcal urethritis in men.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1045676Documentos Relacionados
- Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men.
- Oxytetracycline in the treatment of ocular rosacea: a double-blind trial.
- Double-blind controlled trial of azathioprine in the treatment of multiple sclerosis.
- Ampicillin plus probenecid compared with procaine penicillin plus probenecid in the treatment of gonorrhoea.
- Double-Blind Clinical Trials of Oral Cyclacillin and Ampicillin
